Startups
4basebio specializes in synthetic DNA design and manufacturing for vaccines, gene therapy, and genetic research, offering fast, safe, and scalable solutions.
Mentions in press and media 9
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Feb 16, 2026 | Director Dealing | Director Dealing Mon, Feb 16, 2026 08:00 CET Report this content 16 February 2026 4basebio PLC ("4basebio" or the "Company") Director Dealing Cambridge, UK, 16 February 2026 – 4basebio PLC (AIM: 4BB), an innovation drive... |
| Jun 27, 2025 | Result of AGM | Result of AGM Fri, Jun 27, 2025 19:05 CET Report this content 27 June 2025 4basebio PLC ("4basebio" or the "Company") Result of AGM Cambridge, UK, 25 June 2025 – 4basebio PLC (AIM: 4BB), an innovation-led provider of nov... |
| Jun 25, 2025 | Exercise of Options | Exercise of Options Wed, Jun 25, 2025 08:00 CET Report this content 25 June 2025 4basebio PLC ("4basebio" or the "Company") Exercise of Options Cambridge, UK, 25 June 2025 – 4basebio PLC (AIM: 4BB), an innovation-led pro... |
| Apr 2, 2025 | 4basebio receives MHRA GMP licence for manufacture and supply of synthetic DNA | Cambridge, UK, 02 April 2025 – 4basebio PLC, a company which develops and commercialises the large-scale manufacture of synthetic DNA as well as nanoparticle delivery solutions, announces that it has received Good Manufacturing Practice (GM... |
| Mar 3, 2025 | Circio´s leading position in circular RNA therapeutics highlighted by continued broad coverage in international life science industry media | Circio´s leading position in circular RNA therapeutics highlighted by continued broad coverage in international life science industry media Mon, Mar 03, 2025 07:00 CET Report this content More than 50 articles and interviews featuring Circi... |
| Jan 21, 2025 | 4basebio partners with Circio to build and test circVec synthetic DNA vectors for genetic medicine and vaccines | 4basebio partners with Circio to build and test circVec synthetic DNA vectors for genetic medicine and vaccines Tue, Jan 21, 2025 07:00 CET Report this content 4basebio and Circio are combining Circio´s circVec circular RNA expression syste... |
| Nov 29, 2024 | Director's Dealing | Director's Dealing Fri, Nov 29, 2024 13:30 CET Report this content 29 November 2024 4basebio plc (“4basebio” or the "Company") Director’s Dealing 29 November 2024 – 4basebio PLC (AIM: 4BB) (“4basebio” or the “Company”), which deve... |
| Nov 15, 2024 | Holding(s) in Company | Holding(s) in Company Fri, Nov 15, 2024 18:30 CET Report this content TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possib... |
Reviews 0
FAQ about 4basebio.com
What has the press written about 4basebio.com?
Parsers VC has collected 9 articles mentioning 4basebio.com, among them “Director Dealing” (Feb 16, 2026) and “Result of AGM” (Jun 27, 2025).
Is 4basebio.com still active?
Yes, 4basebio.com is active; its latest activity on Parsers VC dates from Sep 28, 2026.